Rybelsus Lawsuit 2026: MDL Status, Claims, and Why There’s No Settlement Yet

Quick Answer

• Rybelsus injury lawsuits are real and sit in federal MDL 3094, before Judge Karen Marston in Pennsylvania.
• Settlement amount: not yet determined. No class action, settlement fund, or claim form has been confirmed.
• Key date: Rule 702 expert hearing ran September 14 to 18, 2026. Closing arguments were set for October 13.

The Rybelsus lawsuit is a set of individual injury cases against Novo Nordisk, the maker of the oral semaglutide pill. They’re part of a federal MDL, not a class action. No settlement has been announced.

This affects people who took Rybelsus and developed serious stomach or vision problems. The date that matters most is your state’s filing deadline, because no court-wide sign-up date exists.

You may want to read Dupixent Class Action Lawsuit 2026: MDL 3180 Status, CTCL Claims, and Why There Is No Settlement Yet

This article covers MDL status, what the judge has ruled, and what’s still unconfirmed. One surprising detail: the court’s own transfer order lists Rybelsus among the five original MDL drugs, yet public case counts aren’t broken out by drug.

The Facts

Is there a Rybelsus lawsuit?

Yes. Rybelsus injury lawsuits are pending in federal court against Novo Nordisk, and the defendants deny the allegations.

The cases sit in the U.S. District Court for the Eastern District of Pennsylvania as part of MDL 3094. The Judicial Panel on Multidistrict Litigation created the MDL on February 2, 2024. Judge Gene Pratter first held it. Judge Karen S. Marston took over June 6, 2024, after Pratter’s death.

Plaintiffs allege the manufacturers failed to warn about serious side effects. The court’s MDL page states that the Novo Nordisk defendants and Eli Lilly deny these allegations.

Is there a Rybelsus class action lawsuit?

No Rybelsus class action has been confirmed. The cases are individual injury lawsuits consolidated for pretrial work, not one class suing together.

Several law firm pages state this plainly. One says there’s currently no class action over Rybelsus, and plaintiffs file product liability suits instead. A tracker page that checked court records said no public settlement program was identified.

Here’s the difference. In a class action, one case speaks for everyone and a settlement pays class members. In an MDL, each plaintiff keeps an individual case, and the judge coordinates shared issues.

If a page promises a “class action payout” for Rybelsus, ask for the case name and number. I couldn’t find one.

Is Rybelsus part of the GLP-1 MDL?

Yes. The JPML’s own transfer order says the centralization order covered five products, including Rybelsus.

The order lists Ozempic, Wegovy, and Rybelsus, each containing semaglutide and made by Novo Nordisk. It also lists Trulicity and Mounjaro, made by Eli Lilly. Victoza and Zepbound were later added by agreement, per an August 15, 2025 memorandum.

The MDL splits into two tracks:

• MDL 3094: gastrointestinal injuries such as gastroparesis, ileus, and intestinal obstruction.
• MDL 3163: non-arteritic anterior ischemic optic neuropathy (NAION), a vision-loss condition, created in December 2025.

Both are before Judge Marston.

Key Takeaway: Rybelsus is one of the original MDL products, but no class action or settlement has been confirmed for it.

Is there a Rybelsus settlement or payout?

No. No Rybelsus settlement or payout has been announced, so the amount is not yet determined.

A tracker page that reviewed the court’s public orders on October 11, 2026 found no Rule 702 ruling, no bellwether trial date, and no settlement program. Another tracker said the same as of October 1.

Pages showing payout tables for Rybelsus aren’t citing a settlement. They’re estimates or marketing.

A settlement would need a court-approved program and a named administrator. None exists now.

How much is a Rybelsus lawsuit worth?

No verified value exists. Amounts depend on the injury, medical records, your state, and whether your claim survives the court’s expert rulings.

Law firm pages describe the types of damages a plaintiff may seek. These include medical bills, lost wages, and pain and suffering. They describe categories, not payouts.

I found no Rybelsus verdict and no Rybelsus settlement. Any dollar figure quoted today has no court record behind it.

It’s like a price tag on a house nobody has sold. It tells you what someone hopes, not what a buyer paid.

Reality Check: No one legitimate texts you Rybelsus settlement money, because no settlement or claim form exists. Law firm ads and “case review” pages are lead generation, not payment notices. Anyone asking for bank details to release a Rybelsus payout isn’t part of any court process.

Who may qualify to file a Rybelsus lawsuit?

You may qualify to bring an individual claim if you took Rybelsus, suffered a documented injury, and file within your state’s deadline. Eligibility isn’t automatic.

Firms apply their own screening. One firm lists a gastroparesis or bowel obstruction diagnosis and medical records. Another says it’s investigating people aged 75 or younger who needed an emergency room visit or hospital stay. Those are firm criteria, not court rules.

The court added a requirement. In August 2025, Judge Marston held that gastroparesis claims need a gastric emptying study in the medical records, according to a plaintiffs’ firm summary.

If you are curious, also see LA Fitness Lawsuit 2026: FTC Cancellation Case, Text Message Suit, and What You Can Actually Claim

Key Takeaway: Qualifying turns on your records and deadlines, and the court has already tightened what gastroparesis claims must show.

How do you file a Rybelsus lawsuit?

You file through an attorney, since there’s no settlement claim form. These are the steps people typically take.

1. Gather your Rybelsus prescription and pharmacy records.
2. Get your diagnosis and treatment records from your doctors.
3. Note when symptoms began and when you stopped taking Rybelsus.
4. Look up your state’s filing deadline right away.
5. Consult a product liability attorney or compare more than one.
6. Ask how the lawyer is paid and which costs you’d owe.
7. Sign a written fee agreement before work starts.
8. Let the lawyer file in the right federal or state court.

You can seek a case review even after stopping the drug, according to one firm. The injury is what matters.

What records do you need for a Rybelsus claim?

You need proof you took Rybelsus and proof of a diagnosed injury. Law firms commonly ask for prescription information and medical records.

One firm lists the dosage, how long you took it, and records showing an injury diagnosis tied to use. For gastroparesis, the court’s tightened requirement points to a gastric emptying study.

• Pharmacy and prescription records showing Rybelsus
• Doctor visit notes and diagnoses
• Test results, including any gastric emptying study
• Hospital or emergency room records
• Bills and proof of missed work
• A symptom timeline in your own words

Collect these before you call. Records can take weeks to arrive.

How long do you have to file a Rybelsus lawsuit?

You have a limited time set by your state’s statute of limitations, and the deadline varies. A plaintiffs’ firm warns that state deadlines can cut claims off.

I didn’t verify each state’s period. Some states apply a discovery rule, which starts the clock when you knew or should have known of the injury and its cause.

Missing the window can end a case. In a 2009 federal medical device case, Douglass v. NTI-TSS, a Maryland court applied the state’s three-year limit and dismissed the claims as time-barred.

It’s like a warranty claim filed after the warranty expired. The product may still have failed, but the window is shut.

Key Takeaway: Your state’s filing deadline is the date that matters, and the MDL has no public sign-up cutoff for you.

What is the latest Rybelsus lawsuit update?

As of October 19, 2026, the MDL is in pretrial proceedings with no settlement, no bellwether trial date, and no confirmed Rule 702 ruling.

I couldn’t confirm whether a Rule 702 ruling has issued since October 13. Check the court’s MDL page for the current order.

What happened at the September 2026 Rybelsus expert hearing?

Judge Marston held a Rule 702 evidentiary hearing from September 14 through 18, 2026. It tested whether plaintiffs’ experts can testify that GLP-1 drugs cause the alleged injuries.

The court’s MDL page says the hearing covered Cross Cutting Issues 2 and 3. A tracker described them as general causation and preemption or warning adequacy.

This isn’t a trial. It’s a judge deciding which expert opinions a jury could hear. A ruling against plaintiffs on causation could shrink or end claims. A ruling for them keeps the MDL moving.

Defendants plan to challenge the experts’ reliability, per a plaintiffs’ firm summary. A tracker reported a motions-to-strike briefing deadline of October 7.

When will a Rybelsus bellwether trial start?

No bellwether trial date has been set. Multiple trackers say none exists, and the court’s public orders showed none as of October 11, 2026.

Bellwether trials are test cases. They show both sides how juries may react, and they often shape settlement talks. They usually come after the expert rulings.

Settlement talks can’t be verified. Without a ruling and a trial date, anyone predicting a timeline is guessing.

Key Takeaway: No Rybelsus trial date or settlement exists, and the pending expert ruling is the next big event.

Why are people suing Novo Nordisk over Rybelsus?

Plaintiffs allege Novo Nordisk failed to warn patients and doctors about serious side effects. Novo Nordisk and Eli Lilly deny the allegations, per the court’s MDL page.

Rybelsus contains semaglutide, the same active ingredient as Ozempic and Wegovy. It’s the only pill of this type, taken once daily instead of by weekly injection, according to one law firm.

The claims are failure to warn theories. Plaintiffs say the label didn’t adequately disclose gastrointestinal risks at the time they were prescribed. The company says otherwise.

A related guide: How Much Is Burn Pit Compensation in 2026? VA Rates, PACT Act Payouts, and the One Class Action That Actually Paid

A 2023 label change is part of the backdrop. The FDA added an ileus warning to Ozempic in September 2023, per a law firm analysis. I didn’t verify the equivalent Rybelsus label history.

What injuries are alleged in Rybelsus lawsuits?

The MDL covers gastroparesis, ileus, and intestinal obstruction, per the JPML. A separate MDL covers NAION vision loss.

Some law firm pages list more, including pancreatitis and gallbladder disease. Those come from firm marketing, not the court’s MDL definition.

Each claim needs medical proof. An allegation on a firm page isn’t a diagnosis.

What did Judge Marston rule in 2025?

In August 2025, Judge Marston largely denied the drugmakers’ motion to dismiss, letting key claims proceed. She also narrowed the case.

Reports say she struck medical monitoring and design defect claims, finding design defect preempted by FDA rules. She called the plaintiffs’ negligence claims overly broad.

A separate ruling, per a plaintiffs’ firm, required a gastric emptying study for gastroparesis claims. That filtered out cases without that test.

These rulings cut both ways. The case survived, but fewer claims qualify. That’s part of why the count of pending cases rises more slowly than headlines suggest.

Key Takeaway: The 2025 rulings kept the MDL alive but narrowed which claims can proceed.

Is the Rybelsus lawsuit the same as the Ozempic lawsuit?

They’re in the same MDL but involve different drugs and the same maker. Ozempic and Wegovy are injections, and Rybelsus is a daily pill, all from Novo Nordisk.

Eli Lilly’s Mounjaro and Trulicity are in the same MDL as co-defendant products. The cases share the master complaint and the judge.

New Jersey runs a parallel state proceeding. A court application lists the medications as Ozempic, Rybelsus, Victoza, and Wegovy, and a tracker names Judge Gregg Padovano as managing it.

If you took Rybelsus, your case may travel with the Ozempic cases on shared rulings. Product-specific facts, like your dose and records, still matter.

What Happens Next

No settlement date exists, so these are the stages to watch.

• October 13, 2026: Closing arguments set on the Rule 702 motions, per an October 8 order.
• Expected after closing arguments: A ruling on which expert opinions the court will allow. Date not yet confirmed.
• Reported: Fact discovery closes December 18, 2026 for Eli Lilly and February 26, 2027 for Novo Nordisk, per one law firm summary. Check the docket.
• Not yet confirmed: Bellwether trial dates and any settlement program.

Frequently Asked Questions

Is there a Rybelsus class action lawsuit?

No class action has been confirmed.
Rybelsus cases are individual lawsuits in a federal MDL.
Check any “class action” claim for a case name and number.

Is Rybelsus part of the Ozempic lawsuit?

Yes, both are in MDL 3094.
The JPML’s order lists Ozempic, Wegovy, and Rybelsus as Novo Nordisk products.
Rybelsus is the oral pill.

How much is the Rybelsus settlement?

No settlement amount exists.
No fund, administrator, or claim form has been confirmed.
Payout tables online lack a court record.

Can I still sue if I stopped taking Rybelsus?

You may be able to, according to one law firm.
The injury and your records matter more than current use.
State deadlines still apply.

Who is the judge in the Rybelsus lawsuit?

Judge Karen S. Marston of the Eastern District of Pennsylvania.
She took over June 6, 2024, after Judge Pratter’s death.
She also handles the NAION MDL 3163.

How many Rybelsus lawsuits are there?

Public counts aren’t broken out by drug.
MDL 3094 had about 3,928 pending cases in August 2026 and 4,025 on October 1, per trackers citing the JPML.
Other pages cite different numbers.

Does Rybelsus cause vision loss?

Some plaintiffs allege NAION vision loss from semaglutide drugs.
Those claims sit in a separate MDL 3163.
About 200 cases were pending in August 2026.

If you took Rybelsus and were hurt, gather your prescription and medical records now. Then find your state’s filing deadline and ask any lawyer about it first.

Skip any message promising a Rybelsus payout. As of October 19, 2026, the court’s next step was a ruling on the expert hearing that closed arguments set for October 13.

Explore this too: Hair Straightening Lawsuit 2026: No Settlement Yet, 12,000+ Cases and the Real Deadlines